Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Vertex Pharmaceuticals Shares Outstanding 2010-2024 | VRTX

Vertex Pharmaceuticals shares outstanding history from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Vertex Pharmaceuticals shares outstanding for the quarter ending September 30, 2024 were 0.261B, a 0.15% increase year-over-year.
  • Vertex Pharmaceuticals 2023 shares outstanding were 0.261B, a 0.54% increase from 2022.
  • Vertex Pharmaceuticals 2022 shares outstanding were 0.259B, a 0.31% decline from 2021.
  • Vertex Pharmaceuticals 2021 shares outstanding were 0.26B, a 1.33% decline from 2020.
  
Vertex Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2023 261
2022 259
2021 260
2020 263
2019 261
2018 259
2017 253
2016 245
2015 241
2014 235
2013 225
2012 215
2011 209
2010 200
2009 173
Vertex Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
2024-09-30 261
2024-06-30 258
2024-03-31 261
2023-12-31 261
2023-09-30 261
2023-06-30 260
2023-03-31 260
2022-12-31 259
2022-09-30 260
2022-06-30 259
2022-03-31 258
2021-12-31 260
2021-09-30 260
2021-06-30 261
2021-03-31 262
2020-12-31 263
2020-09-30 264
2020-06-30 263
2020-03-31 264
2019-12-31 261
2019-09-30 260
2019-06-30 260
2019-03-31 260
2018-12-31 259
2018-09-30 260
2018-06-30 259
2018-03-31 259
2017-12-31 253
2017-09-30 250
2017-06-30 252
2017-03-31 249
2016-12-31 245
2016-09-30 245
2016-06-30 244
2016-03-31 244
2015-12-31 241
2015-09-30 242
2015-06-30 241
2015-03-31 239
2014-12-31 235
2014-09-30 236
2014-06-30 234
2014-03-31 233
2013-12-31 225
2013-09-30 231
2013-06-30 222
2013-03-31 215
2012-12-31 215
2012-09-30 214
2012-06-30 211
2012-03-31 219
2011-12-31 209
2011-09-30 219
2011-06-30 204
2011-03-31 202
2010-12-31 200
2010-09-30 201
2010-06-30 200
2010-03-31 199
2009-12-31 173
2009-09-30 179
2009-06-30 173
2009-03-31 156
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $115.376B $9.869B
Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's main area of focus is cystic fibrosis. The company's lead marketed products are Trikafta, Symdeko/Symkevi, Orkambi and Kalydeco, which are collectively approved to treat the people with CF in North America, Europe and Australia. Trikafta, Vertex's triple combination regimen, was approved by the FDA for the treatment of CF in people aged 12 years and older who have at least one F508del mutation. While CF remains the main area of focus, Vertex is also developing treatments for sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, type 1 diabetes, pain, alpha-1 antitrypsin deficiency and muscular dystrophies. Pimodivir/VX-787, for the treatment of influenza, was out-licensed to Janssen while oncology candidates VX-970, VX-984 and VX-803 were divested to Merck KGaA.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $150.482B 14.57
Bristol Myers Squibb (BMY) United States $118.101B 49.77
Gilead Sciences (GILD) United States $109.360B 19.81
CSL (CSLLY) Australia $85.433B 0.00
Regeneron Pharmaceuticals (REGN) United States $81.824B 18.62
GSK (GSK) United Kingdom $69.348B 8.02
Argenex SE (ARGX) Netherlands $34.355B 0.00
Alnylam Pharmaceuticals (ALNY) United States $30.216B 0.00
BioNTech SE (BNTX) Germany $25.508B 0.00
Biogen (BIIB) United States $22.649B 9.73
Illumina (ILMN) United States $21.411B 78.04
BeiGene (BGNE) Cayman Islands $18.288B 0.00
Moderna (MRNA) United States $14.350B 0.00
Incyte (INCY) United States $13.593B 0.00
Genmab (GMAB) Denmark $13.566B 19.90
Insmed (INSM) United States $13.189B 0.00
BioMarin Pharmaceutical (BMRN) United States $11.810B 27.42
Vaxcyte (PCVX) United States $10.853B 0.00
Bio-Techne Corp (TECH) United States $10.546B 40.72
Sarepta Therapeutics (SRPT) United States $10.184B 91.91
Exact Sciences (EXAS) United States $9.979B 0.00
Exelixis (EXEL) United States $9.827B 22.34
Revolution Medicines (RVMD) United States $9.499B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.375B 31.86
QIAGEN (QGEN) Netherlands $9.311B 19.16
Intra-Cellular Therapies (ITCI) United States $8.837B 0.00
Roivant Sciences (ROIV) United Kingdom $8.364B 0.00
Ascendis Pharma (ASND) Denmark $7.546B 0.00
Repligen (RGEN) United States $7.199B 93.79
Legend Biotech (LEGN) United States $7.001B 0.00
Cytokinetics (CYTK) United States $6.029B 0.00
Blueprint Medicines (BPMC) United States $6.010B 0.00
Nuvalent (NUVL) United States $5.900B 0.00
Viking Therapeutics (VKTX) United States $5.740B 0.00
Halozyme Therapeutics (HALO) United States $5.701B 12.88
Avidity Biosciences (RNA) United States $5.160B 0.00
Krystal Biotech (KRYS) United States $5.115B 84.69
ADMA Biologics Inc (ADMA) United States $4.877B 51.58
Arcellx (ACLX) United States $4.736B 0.00
Biohaven (BHVN) United States $4.682B 0.00
Axsome Therapeutics (AXSM) United States $4.626B 0.00
Alkermes (ALKS) Ireland $4.446B 14.94
Ultragenyx Pharmaceutical (RARE) United States $4.168B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.009B 0.00
Guardant Health (GH) United States $3.791B 0.00
ImmunityBio (IBRX) United States $3.728B 0.00
Immunovant (IMVT) United States $3.702B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.686B 0.00
Apellis Pharmaceuticals (APLS) United States $3.606B 0.00
Denali Therapeutics (DNLI) United States $3.503B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.152B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $3.045B 0.00
Edgewise Therapeutics (EWTX) United States $2.984B 0.00
Merus (MRUS) Netherlands $2.977B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.962B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.920B 0.00
Vera Therapeutics (VERA) United States $2.907B 0.00
Amicus Therapeutics (FOLD) United States $2.845B 0.00
SpringWorks Therapeutics (SWTX) United States $2.821B 0.00
Kymera Therapeutics (KYMR) United States $2.775B 0.00
Vericel (VCEL) United States $2.756B 930.50
ACADIA Pharmaceuticals (ACAD) United States $2.697B 20.78
Scholar Rock Holding (SRRK) United States $2.608B 0.00
Zai Lab (ZLAB) China $2.605B 0.00
Janux Therapeutics (JANX) United States $2.572B 0.00
Belite Bio (BLTE) United States $2.521B 0.00
Iovance Biotherapeutics (IOVA) United States $2.496B 0.00
Twist Bioscience (TWST) United States $2.453B 0.00
Longboard Pharmaceuticals (LBPH) United States $2.337B 0.00
Protagonist Therapeutics (PTGX) United States $2.303B 14.53
Geron (GERN) United States $2.291B 0.00
IDEAYA Biosciences (IDYA) United States $2.235B 0.00
CG Oncology (CGON) United States $2.218B 0.00
Keros Therapeutics (KROS) United States $2.172B 0.00
WAVE Life Sciences (WVE) Singapore $2.167B 0.00
Akero Therapeutics (AKRO) United States $2.166B 0.00
Bavarian Nordic (BVNRY) Denmark $2.118B 12.98
Ligand Pharmaceuticals (LGND) United States $2.113B 52.74
Apogee Therapeutics (APGE) United States $2.095B 0.00
Beam Therapeutics (BEAM) United States $2.094B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.021B 0.00
NeoGenomics (NEO) United States $1.972B 0.00
MannKind (MNKD) United States $1.892B 49.00
Structure Therapeutics (GPCR) United States $1.877B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.852B 15.39
Tarsus Pharmaceuticals (TARS) United States $1.792B 0.00
NovoCure (NVCR) Jersey $1.783B 0.00
Disc Medicine (IRON) United States $1.770B 0.00
Galapagos (GLPG) Belgium $1.759B 0.00
Fortrea Holdings (FTRE) United States $1.676B 53.37
Celldex Therapeutics (CLDX) United States $1.657B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.629B 0.00
Nurix Therapeutics (NRIX) United States $1.614B 0.00
Viridian Therapeutics (VRDN) United States $1.603B 0.00
Neumora Therapeutics (NMRA) United States $1.593B 0.00
Certara (CERT) United States $1.590B 44.91
Dynavax Technologies (DVAX) United States $1.579B 92.39
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.503B 0.00
Arvinas (ARVN) United States $1.487B 0.00
Intellia Therapeutics (NTLA) United States $1.439B 0.00
Spyre Therapeutics (SYRE) United States $1.384B 0.00
Myriad Genetics (MYGN) United States $1.366B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.363B 0.00
MiMedx (MDXG) United States $1.358B 35.54
Travere Therapeutics (TVTX) United States $1.357B 0.00
Praxis Precision Medicines (PRAX) United States $1.356B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.346B 0.00
Arcus Biosciences (RCUS) United States $1.328B 0.00
Novavax (NVAX) United States $1.281B 0.00
Kura Oncology (KURA) United States $1.241B 0.00
Mesoblast (MESO) Australia $1.235B 0.00
Upstream Bio (UPB) United States $1.219B 0.00
Gyre Therapeutics (GYRE) United States $1.208B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.200B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.181B 0.00
ANI Pharmaceuticals (ANIP) United States $1.171B 15.96
Bicara Therapeutics (BCAX) United States $1.051B 0.00
Applied Therapeutics (APLT) United States $1.039B 0.00
Zymeworks (ZYME) United States $1.017B 0.00
Septerna (SEPN) $1.016B 0.00
Cogent Biosciences (COGT) United States $1.001B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.974B 0.00
Vir Biotechnology (VIR) United States $0.954B 0.00
LENZ Therapeutics (LENZ) United States $0.953B 0.00
Immatics (IMTX) Germany $0.932B 0.00
ArriVent BioPharma (AVBP) United States $0.924B 0.00
Nuvation Bio (NUVB) United States $0.872B 0.00
Liquidia Technologies (LQDA) United States $0.860B 0.00
89BIO (ETNB) United States $0.848B 0.00
Tyra Biosciences (TYRA) United States $0.820B 0.00
Rapport Therapeutics (RAPP) United States $0.815B 0.00
Castle Biosciences (CSTL) United States $0.809B 144.35
AbCellera Biologics (ABCL) Canada $0.800B 0.00
Cytek Biosciences (CTKB) United States $0.790B 0.00
Erasca (ERAS) United States $0.789B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.785B 0.00
Pliant Therapeutics (PLRX) United States $0.778B 0.00
Avid Bioservices (CDMO) United States $0.778B 0.00
Pacira BioSciences (PCRX) United States $0.772B 7.27
Cullinan Therapeutics (CGEM) United States $0.763B 0.00
Prothena (PRTA) Ireland $0.756B 0.00
Replimune (REPL) United States $0.749B 0.00
CARGO Therapeutics (CRGX) United States $0.742B 0.00
Anavex Life Sciences (AVXL) United States $0.699B 0.00
BioAge Labs (BIOA) United States $0.687B 0.00
CorMedix Inc (CRMD) United States $0.672B 0.00
Entrada Therapeutics (TRDA) United States $0.665B 11.18
Arbutus Biopharma (ABUS) United States $0.661B 0.00
Adaptive Biotechnologies (ADPT) United States $0.661B 0.00
Dianthus Therapeutics (DNTH) United States $0.659B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.641B 0.00
Mineralys Therapeutics (MLYS) United States $0.640B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.629B 0.00
Oric Pharmaceuticals (ORIC) United States $0.627B 0.00
Stoke Therapeutics (STOK) United States $0.615B 0.00
Oculis Holding AG (OCS) Switzerland $0.608B 0.00
AnaptysBio (ANAB) United States $0.608B 0.00
Zenas BioPharma (ZBIO) United States $0.606B 0.00
Tectonic Therapeutic (TECX) United States $0.603B 0.00
Immunome (IMNM) United States $0.586B 0.00
Annexon (ANNX) United States $0.582B 0.00
ChromaDex (CDXC) United States $0.574B 752.00
IGM Biosciences (IGMS) United States $0.567B 0.00
Abivax SA (ABVX) France $0.564B 0.00
Third Harmonic Bio (THRD) United States $0.561B 0.00
CureVac (CVAC) Germany $0.560B 4.55
Humacyte (HUMA) United States $0.556B 0.00
Astria Therapeutics (ATXS) United States $0.550B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.540B 0.00
MBX Biosciences (MBX) United States $0.533B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.528B 0.00
Sana Biotechnology (SANA) United States $0.527B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.521B 0.00
Pharming Group (PHAR) Netherlands $0.512B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.511B 0.00
PureTech Health (PRTC) United States $0.509B 0.00
Terns Pharmaceuticals (TERN) United States $0.502B 0.00
GH Research (GHRS) Ireland $0.500B 0.00
Olema Pharmaceuticals (OLMA) United States $0.500B 0.00
GRAIL (GRAL) United States $0.497B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.490B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.489B 0.00
Alumis (ALMS) United States $0.489B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.486B 0.00
REGENXBIO (RGNX) United States $0.474B 0.00
ACELYRIN, INC (SLRN) United States $0.474B 0.00
MeiraGTx Holdings (MGTX) United States $0.467B 0.00
Celcuity (CELC) United States $0.463B 0.00
Emergent Biosolutions (EBS) United States $0.448B 0.00
Cartesian Therapeutics (RNAC) United States $0.446B 0.00
Aura Biosciences (AURA) United States $0.446B 0.00
Allogene Therapeutics (ALLO) United States $0.445B 0.00
Foghorn Therapeutics (FHTX) United States $0.434B 0.00
Prime Medicine (PRME) United States $0.416B 0.00
Tango Therapeutics (TNGX) United States $0.414B 0.00
Sangamo Therapeutics (SGMO) United States $0.409B 0.00
Revance Therapeutics (RVNC) United States $0.394B 0.00
Alector (ALEC) United States $0.377B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.358B 0.00
XOMA Royalty (XOMA) United States $0.355B 0.00
Q32 Bio (QTTB) United States $0.354B 0.00
Northwest Biotherapeutics (NWBO) United States $0.354B 0.00
MaxCyte (MXCT) United States $0.351B 0.00
Codexis (CDXS) United States $0.346B 0.00
Contineum Therapeutics (CTNM) United States $0.343B 0.00
Kamada (KMDA) Israel $0.340B 21.11
EnGene Holdings (ENGN) Canada $0.333B 0.00
Alpha Teknova (TKNO) United States $0.331B 0.00
AC Immune (ACIU) Switzerland $0.324B 0.00
Absci (ABSI) United States $0.312B 0.00
Jasper Therapeutics (JSPR) United States $0.310B 0.00
Design Therapeutics (DSGN) United States $0.310B 0.00
Kodiak Sciences (KOD) United States $0.297B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.294B 0.00
Prima BioMed (IMMP) Australia $0.294B 0.00
C4 Therapeutics (CCCC) United States $0.293B 0.00
ITeos Therapeutics (ITOS) United States $0.289B 0.00
Voyager Therapeutics (VYGR) United States $0.288B 7.42
Vanda Pharmaceuticals (VNDA) United States $0.287B 0.00
Rezolute (RZLT) United States $0.287B 0.00
UniQure (QURE) Netherlands $0.284B 0.00
Nautilus Biotechnology (NAUT) United States $0.281B 0.00
Artiva Biotherapeutics (ARTV) United States $0.274B 0.00
Mersana Therapeutics (MRSN) United States $0.274B 0.00
Eton Pharmaceuticals (ETON) United States $0.271B 0.00
Poseida Therapeutics (PSTX) United States $0.270B 0.00
Atea Pharmaceuticals (AVIR) United States $0.265B 0.00
Urogen Pharma (URGN) United States $0.262B 0.00
Lifecore Biomedical (LFCR) United States $0.261B 0.00
Abeona Therapeutics (ABEO) United States $0.256B 0.00
Neurogene (NGNE) United States $0.256B 0.00
ATyr Pharma (ATYR) United States $0.255B 0.00
Ocugen (OCGN) United States $0.255B 0.00
Anika Therapeutics (ANIK) United States $0.250B 0.00
Fate Therapeutics (FATE) United States $0.248B 0.00
Precigen (PGEN) United States $0.233B 0.00
Biomea Fusion (BMEA) United States $0.233B 0.00
Semper Paratus Acquisition (TVGN) United States $0.232B 0.00
Trevi Therapeutics (TRVI) United States $0.231B 0.00
Benitec Biopharma (BNTC) United States $0.229B 0.00
TScan Therapeutics (TCRX) United States $0.223B 0.00
Sutro Biopharma (STRO) United States $0.223B 0.00
Molecular Partners AG (MOLN) Switzerland $0.220B 0.00
Climb Bio (CLYM) United States $0.218B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.217B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.213B 0.00
GENFIT S.A (GNFT) France $0.213B 0.00
BioStem Technologies (BSEM) $0.211B 18.68
Inhibrx Biosciences (INBX) United States $0.207B 0.00
Zura Bio (ZURA) United States $0.206B 0.00
Editas Medicine (EDIT) United States $0.205B 0.00
Solid Biosciences (SLDB) United States $0.204B 0.00
XBiotech (XBIT) United States $0.203B 0.00
Amarin (AMRN) Ireland $0.202B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.199B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.197B 0.00
Compass Therapeutics (CMPX) United States $0.195B 0.00
Opthea (OPT) Australia $0.190B 0.00
Inozyme Pharma (INZY) United States $0.181B 0.00
Caribou Biosciences (CRBU) United States $0.180B 0.00
Tenaya Therapeutics (TNYA) United States $0.180B 0.00
Verastem (VSTM) United States $0.176B 0.00
Kyverna Therapeutics (KYTX) United States $0.176B 0.00
ScPharmaceuticals (SCPH) United States $0.176B 0.00
Nkarta (NKTX) United States $0.175B 0.00
Actuate Therapeutics (ACTU) United States $0.174B 0.00
DiaMedica Therapeutics (DMAC) United States $0.173B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.173B 0.00
Instil Bio (TIL) United States $0.171B 0.00
Greenwich LifeSciences (GLSI) United States $0.168B 0.00
2seventy Bio (TSVT) United States $0.166B 0.00
Bright Minds Biosciences (DRUG) United States $0.164B 0.00
Fulcrum Therapeutics (FULC) United States $0.162B 0.00
Gossamer Bio (GOSS) United States $0.162B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.154B 0.00
Checkpoint Therapeutics (CKPT) United States $0.152B 0.00
PepGen (PEPG) United States $0.146B 0.00
Black Diamond Therapeutics (BDTX) United States $0.144B 0.00
Inventiva S.A (IVA) France $0.144B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.144B 0.00
Elutia (ELUT) United States $0.143B 0.00
Sagimet Biosciences (SGMT) United States $0.135B 0.00
Puma Biotechnology (PBYI) United States $0.135B 5.71
Seer (SEER) United States $0.134B 0.00
Cardiff Oncology (CRDF) United States $0.134B 0.00
Skye Bioscience (SKYE) United States $0.132B 0.00
Adverum Biotechnologies (ADVM) United States $0.130B 0.00
Candel Therapeutics (CADL) United States $0.130B 0.00
CAMP4 Therapeutics (CAMP) United States $0.129B 0.00
Compugen (CGEN) Israel $0.129B 72.00
Ventyx Biosciences (VTYX) United States $0.126B 0.00
Scilex Holding (SCLX) United States $0.125B 0.00
Vigil Neuroscience (VIGL) United States $0.124B 0.00
Cabaletta Bio (CABA) United States $0.124B 0.00
Oncobiologics (OTLK) United States $0.124B 0.00
Repare Therapeutics (RPTX) Canada $0.122B 0.00
Alto Neuroscience (ANRO) United States $0.121B 0.00
Innate Pharma S.A (IPHA) France $0.121B 0.00
Seres Therapeutics (MCRB) United States $0.118B 0.00
Adherex Technologies (FENC) United States $0.117B 0.00
TELA Bio (TELA) United States $0.115B 0.00
InflaRx (IFRX) Germany $0.113B 0.00
Adlai Nortye (ANL) Cayman Islands $0.111B 0.00
Cidara Therapeutics (CDTX) United States $0.110B 0.00
Rani Therapeutics Holdings (RANI) United States $0.110B 0.00
Cellectis S.A (CLLS) France $0.109B 0.00
Akoya Biosciences (AKYA) United States $0.107B 0.00
Inovio Pharmaceuticals (INO) United States $0.105B 0.00
INmune Bio (INMB) United States $0.104B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.103B 0.00
BioHarvest Sciences (BHST) Canada $0.102B 0.00
Coya Therapeutics (COYA) United States $0.101B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.100B 0.00
Monopar Therapeutics (MNPR) United States $0.100B 0.00
Nuvectis Pharma (NVCT) United States $0.099B 0.00
Adagene (ADAG) China $0.098B 0.00
Coherus BioSciences (CHRS) United States $0.095B 0.00
Immunic (IMUX) United States $0.095B 0.00
MediciNova (MNOV) United States $0.093B 0.00
Generation Bio (GBIO) United States $0.093B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.093B 0.00
Annovis Bio (ANVS) United States $0.092B 0.00
Invivyd (IVVD) United States $0.092B 0.00
Galena Biopharma (SLS) United States $0.091B 0.00
HilleVax (HLVX) United States $0.091B 0.00
Genenta Science S.p.A (GNTA) Italy $0.090B 0.00
Allakos (ALLK) United States $0.090B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.089B 0.00
Genelux (GNLX) United States $0.086B 0.00
Adicet Bio (ACET) United States $0.085B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.084B 0.00
23andMe Holding (ME) United States $0.084B 0.00
FibroBiologics (FBLG) United States $0.082B 0.00
Oncolytics Biotech (ONCY) Canada $0.082B 0.00
Ikena Oncology (IKNA) United States $0.081B 0.00
Chimerix (CMRX) United States $0.079B 0.00
PDS Biotechnology (PDSB) United States $0.078B 0.00
Clearside Biomedical (CLSD) United States $0.078B 0.00
Quince Therapeutics (QNCX) United States $0.078B 0.00
I-Mab (IMAB) China $0.078B 0.00
Aerovate Therapeutics (AVTE) United States $0.077B 0.00
Renovaro (RENB) United States $0.075B 0.00
Werewolf Therapeutics (HOWL) United States $0.074B 0.00
VistaGen Therapeutics (VTGN) United States $0.074B 0.00
ZIVO Bioscience (ZIVO) United States $0.074B 0.00
Ovid Therapeutics (OVID) United States $0.073B 0.00
BioAtla (BCAB) United States $0.073B 0.00
CytomX Therapeutics (CTMX) United States $0.070B 5.25
Leap Therapeutics (LPTX) United States $0.069B 0.00
BeyondSpring (BYSI) United States $0.067B 0.00
Aligos Therapeutics (ALGS) United States $0.066B 0.00
ALX Oncology Holdings (ALXO) United States $0.065B 0.00
Celularity (CELU) United States $0.064B 0.00
Immuneering (IMRX) United States $0.063B 0.00
Atara Biotherapeutics (ATRA) United States $0.063B 0.00
Spero Therapeutics (SPRO) United States $0.063B 16.57
X4 Pharmaceuticals (XFOR) United States $0.063B 0.00
CervoMed (CRVO) United States $0.062B 0.00
Aileron Therapeutics (ALRN) United States $0.061B 0.00
Agenus (AGEN) United States $0.060B 0.00
Boundless Bio (BOLD) United States $0.060B 0.00
Bluebird Bio (BLUE) United States $0.059B 0.00
Entera Bio (ENTX) Israel $0.058B 0.00
IO Biotech (IOBT) Denmark $0.057B 0.00
Elicio Therapeutics (ELTX) United States $0.056B 0.00
Theratechnologies (THTX) Canada $0.055B 0.00
Precision BioSciences (DTIL) United States $0.055B 0.00
OnKure Therapeutics (OKUR) United States $0.055B 0.00
Aadi Bioscience (AADI) United States $0.054B 0.00
Shattuck Labs (STTK) United States $0.054B 0.00
Connect Biopharma Holdings (CNTB) United States $0.054B 0.00
Kezar Life Sciences (KZR) United States $0.054B 0.00
Enzo Biochem (ENZ) United States $0.053B 0.00
Vor Biopharma (VOR) $0.053B 0.00
Cue Biopharma (CUE) United States $0.053B 0.00
Kronos Bio (KRON) United States $0.051B 0.00
BGM Group (BGM) China $0.050B 0.00
VTv Therapeutics (VTVT) United States $0.049B 0.00
Affimed (AFMD) Germany $0.048B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.048B 0.00
DBV Technologies S.A (DBVT) France $0.047B 0.00
Immix Biopharma (IMMX) United States $0.047B 0.00
CalciMedica (CALC) United States $0.045B 0.00
Xilio Therapeutics (XLO) United States $0.045B 0.00
Fortress Biotech (FBIO) United States $0.044B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.043B 0.00
Omega Therapeutics (OMGA) United States $0.042B 0.00
HCW Biologics (HCWB) United States $0.042B 0.00
Intensity Therapeutics (INTS) United States $0.042B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.042B 0.00
Rallybio (RLYB) United States $0.040B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.039B 0.00
Clene (CLNN) United States $0.039B 0.00
Beyond Air (XAIR) United States $0.038B 0.00
Lumos Pharma (LUMO) United States $0.037B 0.00
Rapt Therapeutics (RAPT) United States $0.037B 0.00
NextCure (NXTC) United States $0.037B 0.00
Dyadic (DYAI) United States $0.036B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.035B 0.00
OKYO Pharma (OKYO) $0.035B 0.00
Lexaria Bioscience (LEXX) Canada $0.034B 0.00
Elevation Oncology (ELEV) United States $0.034B 0.00
Alpha Cognition (ACOG) Canada $0.034B 0.00
HOOKIPA Pharma (HOOK) United States $0.034B 0.00
Lantern Pharma (LTRN) United States $0.033B 0.00
Promis Neurosciences (PMN) Canada $0.032B 0.00
Grace Therapeutics (GRCE) Canada $0.032B 0.00
AN2 Therapeutics (ANTX) United States $0.032B 0.00
Estrella Immunopharma (ESLA) United States $0.031B 0.00
SAB Biotherapeutics (SABS) United States $0.030B 0.00
KALA BIO (KALA) United States $0.030B 0.00
Passage Bio (PASG) United States $0.030B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.028B 0.00
Pluri (PLUR) Israel $0.028B 0.00
Opus Genetics (IRD) United States $0.028B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
GeoVax Labs (GOVX) United States $0.027B 0.00
MiNK Therapeutics (INKT) United States $0.027B 0.00
RenovoRx (RNXT) United States $0.027B 0.00
Longeveron (LGVN) United States $0.027B 0.00
BioXcel Therapeutics (BTAI) United States $0.026B 0.00
Cadrenal Therapeutics (CVKD) United States $0.025B 0.00
Athira Pharma (ATHA) United States $0.025B 0.00
Ocean Biomedical (OCEA) United States $0.025B 0.00
Equillium (EQ) United States $0.025B 0.00
Chemomab Therapeutics (CMMB) Israel $0.023B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.023B 0.00
LakeShore Biopharma (LSB) China $0.023B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
Bionano Genomics (BNGO) United States $0.023B 0.00
Curis (CRIS) United States $0.023B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.022B 0.00
Bolt Biotherapeutics (BOLT) United States $0.021B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.021B 0.00
Cocrystal Pharma (COCP) United States $0.021B 0.00
BioAffinity Technologies (BIAF) United States $0.021B 0.00
BRIACELL THERAP (BCTX) Canada $0.021B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.021B 0.00
Femasys (FEMY) United States $0.020B 0.00
Spruce Biosciences (SPRB) United States $0.020B 0.00
Pulmatrix (PULM) United States $0.020B 0.00
Cyclo Therapeutics (CYTH) United States $0.020B 0.00
UNITY Biotechnology (UBX) United States $0.020B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.019B 0.00
Cognition Therapeutics (CGTX) United States $0.018B 0.00
Apollomics (APLM) United States $0.018B 0.00
Tenax Therapeutics (TENX) United States $0.017B 0.00
Cara Therapeutics (CARA) United States $0.017B 0.00
Aprea Therapeutics (APRE) United States $0.016B 0.00
Synlogic (SYBX) United States $0.016B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.015B 0.00
Gelteq (GELS) $0.015B 0.00
Novogen (KZIA) Australia $0.015B 0.00
IN8bio (INAB) United States $0.015B 0.00
Cingulate (CING) United States $0.013B 0.00
Exicure (XCUR) United States $0.013B 0.00
Sensei Biotherapeutics (SNSE) United States $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Turnstone Biologics (TSBX) United States $0.011B 0.00
Mustang Bio (MBIO) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
NKGen Biotech (NKGN) United States $0.010B 0.00
Imunon (IMNN) United States $0.010B 0.00
Senti Biosciences (SNTI) United States $0.010B 0.00
Aytu BioPharma (AYTU) United States $0.010B 0.00
Biorestorative Therapies (BRTX) United States $0.010B 0.00
Quantum Biopharma (QNTM) Canada $0.010B 0.00
Onconetix (ONCO) United States $0.009B 0.00
Ensysce Biosciences (ENSC) United States $0.009B 0.00
Evogene (EVGN) Israel $0.009B 0.00
Vincerx Pharma (VINC) United States $0.009B 0.00
Evaxion Biotech (EVAX) Denmark $0.009B 0.00
Soligenix (SNGX) United States $0.009B 0.00
Forte Biosciences (FBRX) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.008B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.008B 0.00
Moleculin Biotech (MBRX) United States $0.008B 0.00
Galecto (GLTO) Denmark $0.008B 0.00
Eyenovia (EYEN) United States $0.008B 0.00
Syros Pharmaceuticals (SYRS) United States $0.007B 0.00
Biora Therapeutics (BIOR) United States $0.007B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.007B 0.00
Edesa Biotech (EDSA) Canada $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Aptose Biosciences (APTO) Canada $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.006B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Vaccinex (VCNX) United States $0.006B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
Organovo Holdings (ONVO) United States $0.005B 0.00
Carmell (CTCX) United States $0.005B 0.00
Bionomics (BNOX) Australia $0.005B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.005B 0.00
TuHURA Biosciences (HURA) United States $0.005B 0.00
Cyclerion Therapeutics (CYCN) United States $0.005B 0.00
Aptevo Therapeutics (APVO) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.004B 0.00
Portage Biotech (PRTG) $0.004B 0.00
Silo Pharma (SILO) United States $0.004B 0.00
BioCardia (BCDA) United States $0.004B 0.00
Biofrontera (BFRI) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Polyrizon (PLRZ) $0.004B 0.00
Pasithea Therapeutics (KTTA) United States $0.004B 0.00
Eterna Therapeutics (ERNA) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
NuCana (NCNA) United Kingdom $0.004B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
Dogwood Therapeutics (DWTX) United States $0.003B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.003B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
GENPREX (GNPX) United States $0.003B 0.00
Synaptogenix (SNPX) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.003B 0.00
NAYA Biosciences (NAYA) United States $0.003B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
Sunshine Biopharma (SBFM) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Citius Oncology (CTOR) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.002B 0.00
GRI Bio (GRI) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
TFF Pharmaceuticals (TFFP) United States $0.001B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.001B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.001B 0.00
Elevai Labs (ELAB) United States $0.000B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.000B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
Windtree Therapeutics (WINT) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00